Project Grant R36DA062074

Award Date 6/1/25
Completion Date 5/31/26
Dollars Obligated $53K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This $385,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to advance integrated treatment for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD) in real-world settings. The key objectives are to: Assess the effectiveness of integrated treatment approaches, including first-line medications and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for patients with co-occurring OUD...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a 5-year study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The research aims to: 1) characterize real-world OUD treatment trajectories in the year following hospital encounters among treatment-naive...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an evidence-based quality improvement...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) provides $1,093,394 to the University of Illinois to develop the "CHICAGO DATA-DRIVEN OUD SCREENING, ENGAGEMENT, TREATMENT AND PLANNING (C-DOSETAP) SYSTEM". The two-year project aims to leverage machine learning, prescription data, and patient-reported measures to assess and address opioid use disorder (OUD) risk and associated health disparities on...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the CFDA 93.279 Drug Use and Addiction Research Programs, provides $770,751 to Oregon Health & Science University (OHSU) from July 1, 2025 to March 31, 2030. The objective of this award is to conduct a comprehensive evaluation of the impact of telehealth expansion on opioid use disorder (OUD) care within community health centers (CHCs). Specifically, the study will: 1) examine rates of OUD-related care (e.g.,...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $594,122 Project Grant to Boulder Care, Inc. to develop and test telehealth workflows for providing buprenorphine treatment for opioid use disorder (OUD) in vulnerable settings. The project aims to address the continued lack of access to OUD treatment, particularly in jails/prisons, emergency departments, residential treatment facilities, rural tribal areas, and during the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $196,236 to The Washington University to conduct research focused on disparities in the prescription and effectiveness of medications to treat opioid use disorder (OUD) during pregnancy. The key objectives of the 5-year project are to: 1) evaluate how race and racial segregation are associated with the use of buprenorphine and methadone as well...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...

PATIENT PERSPECTIVES, FOLLOW-UP PATTERNS, AND COST-EFFECTIVENESS OF A LOW-THRESHOLD MOBILE MEDICAL UNIT PROVIDING OPIOID USE DISORDER CARE IN AN URBAN SETTING - PROJECT SUMMARY AND ABSTRACT THE OPIOID CRISIS AFFECTS THOUSANDS OF LIVES EACH YEAR, DESPITE THE AVAILABILITY OF THERAPIES TO TREAT OPIOID USE DISORDER (OUD). PATIENT-LEVEL BARRIERS (E.G. ABILITY TO SEEK CARE), HEALTHCARE SYSTEM BARRIERS (E.G. INSURANCE), AND SOCIAL BARRIERS (E.G. STIGMA) PREVENT MOTIVATED INDIVIDUALS FROM ACCESSING MEDICATION THERAPY FOR OUD, INCLUDING BUPRENORPHINE. LOW-THRESHOLD APPROACHES TO DELIVERING MEDICATION FOR OUD, SUCH AS MOBILE MEDICAL UNITS, ACKNOWLEDGE AND ADDRESS THESE BARRIERS BY MEETING INDIVIDUALS WHERE THEY ARE. THE SERVICES PROVIDED, POPULATIONS SERVED, AND IMPLEMENTATION LESSONS OF THE MOBILE MEDICAL UNITS OPERATING IN CITY SETTINGS ACROSS THE COUNTRY ARE DOCUMENTED IN THE LITERATURE, BUT LESS IS KNOWN ABOUT THE PATIENT'S OPINION AND/OR SUSTAINABILITY OF THE MOBILE MEDICAL CARE MODEL FOR DELIVERING LOW-THRESHOLD OUD TREATMENT. THIS RESEARCH PROPOSES TO EXPLORE THE PATIENTS' OPINION, UTILIZATION TRENDS, AND ECONOMIC VALUE OF ADDRESSING INEQUITIES IN ACCESS TO OUD TREATMENT WITH THE MOBILE MEDICAL CARE MODEL. THE UNIVERSITY OF ILLINOIS CHICAGO (UIC) COMMUNITY OUTREACH INTERVENTION PROJECT (COIP) HAS AN ESTABLISHED LOW-THRESHOLD MOBILE MEDICAL UNIT THAT PROVIDES OUD TREATMENT IN CHICAGO NEIGHBORHOODS WITH HIGH NEED FOR SUCH SERVICES. IN THE CONTEXT OF THE UIC COIP MOBILE MEDICAL UNIT, THIS RESEARCH AIMS TO: (1) CONDUCT QUALITATIVE INTERVIEWS TO ASCERTAIN THE PATIENTS' PERSPECTIVE ON THE MOBILE MEDICAL UNIT'S ABILITY TO ADDRESS BARRIERS TO ACCESSING TREATMENT FOR OUD. (2) IDENTIFY PATTERNS IN PATIENT FOLLOW-UP WITH THE MOBILE MEDICAL UNIT FOR OUD TREATMENT AND EXAMINE PATIENT CHARACTERISTICS ASSOCIATED WITH CERTAIN FOLLOW-UP PATTERNS, USING GROUP-BASED TRAJECTORY MODELING. (3) ASSESS THE COSTS AND POPULATION-LEVEL BENEFITS OF THE MOBILE MEDICAL UNIT IN AN URBAN SETTING, ACCOUNTING FOR THE DISPROPORTIONATELY HIGHER BENEFIT EXPERIENCED BY INDIVIDUALS WHO ARE DISCONNECTED FROM CARE, THROUGH A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS. AS THE MOBILE MEDICAL CARE MODEL FOR OUD TREATMENT DELIVERY EXPANDS, ENSURING EFFICIENT USE OF HEALTHCARE RESOURCES REQUIRES KNOWLEDGE BEYOND THE REACH AND SERVICES PROVIDED BY MOBILE MEDICAL UNITS. THOUGH THE MOBILE MEDICAL CARE MODEL AIMS TO MINIMIZE ACCESS BARRIERS, A COMPREHENSIVE ANALYSIS OF THE PATIENTS' PERCEIVED BENEFITS, THE FOLLOW-UP PATTERNS, AND THE ECONOMIC VALUE OF ADDRESSING INEQUITIES IN ACCESS TO AFFORDABLE OUD CARE IS NECESSARY FOR INFORMED IMPLEMENTATION AND/OR EXPANSION DECISION MAKING.

Posted 5/21/25, 12:00 AM